Global & United States Laparoscopic Devices Market to 2031

The United States maintains its leading position in the global laparoscopic devices market, supported by its highly advanced healthcare infrastructure, rapid adoption of innovative surgical technologies, and substantial investments in research and development. This leadership is further strengthened by the widespread use of minimally invasive surgical methods, such as laparoscopic and robotic surgeries, which are gradually replacing conventional open surgeries. These minimally invasive techniques offer improved patient outcomes, including reduced postoperative pain, shorter hospital stays, and faster recovery.

A key factor driving this dominance is the growing prevalence of chronic conditions that often require complex surgeries. According to an August 2022 report from the American College of Cardiology, diabetes rates in the US are expected to increase by 39.3% (reaching 55 million people) and obesity rates by 18.3% (totaling 126 million people) between 2025 and 2060, fueling greater demand for laparoscopic and robotic procedures.

The US also leads in technological innovation and design, as evidenced by the rapid growth of robot-assisted surgery systems, expanding at an annual rate of 25%. Over 2,000 hospitals nationwide currently employ robotic surgery platforms. For example, Intuitive Surgical's da Vinci systems performed more than 2.68 million procedures globally in 2024, with a 25% increase in general surgeries in the US driving this growth. Furthermore, in February 2024, the FDA approved Virtual Incision Corporation’s miniaturized robotic-assisted surgical device, the MIRA Surgical System, for colectomy procedures. Additionally, Ethicon (Johnson & Johnson) introduced an AI-powered laparoscopic surgical simulation platform in November 2023. The widespread integration of advanced 4K and 3D imaging systems, alongside continuous enhancements in energy devices and handheld instruments, is expanding laparoscopic capabilities across the country. The strong presence of major international medical device manufacturers, combined with strategic investments in R&D and distribution, reinforces the US’s dominant position. Many new product approvals and launches, such as disposable suction-irrigation systems with built-in smoke filters, anticipated by late 2024 or early 2025, are taking place in this innovative market.

Moreover, the increasing number of ambulatory surgical centers (approximately 9,600 as of 2024) reflects a growing preference for same-day, cost-effective surgical options. Technological breakthroughs, including the FDA’s approval of Levita’s MARS magnetic surgery platform in August 2023, further demonstrate the US’s pioneering role in advancing laparoscopic surgery.